Scintica Inc.

About Scintica Inc.

Scintica Inc. sits in Other / Uncategorized, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Reuters Health · 2026-09-20
  Scintica Inc expands cyclotron capacity to meet Lu-177 demand
  The work builds on more than a decade of radiochemistry collaboration.
• Endpoints News · 2026-10-11
  Scintica Inc announces Phase II readout for lead theranostic candidate
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• FierceBiotech · 2026-11-06
  Scintica Inc appoints new Chief Medical Officer ahead of pivotal trial
  Coverage notes the company's growing footprint in the radioligand therapy space.
• BioPharma Reporter · 2026-12-01
  Scintica Inc signs supply agreement to support late-stage trials
  The work builds on more than a decade of radiochemistry collaboration.
• Imaging Wire · 2026-05-20
  Scintica Inc closes Series C round to scale radiopharma manufacturing
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.